ClinicalTrials.govpublic full text
Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer
pancreatic neoplasms, advanced pancreatic cancer, poly (adp ribose) polymerases, advanced solid tumours, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879879
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.